Sarepta Therapeutics
SRPT
#2373
Rank
C$8.69 B
Marketcap
$89.64
Share price
1.13%
Change (1 day)
-48.57%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

P/S ratio for Sarepta Therapeutics (SRPT)

P/S ratio as of April 2025 (TTM): 3.20

According to Sarepta Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.98. At the end of 2024 the company had a P/S ratio of 6.10.

P/S ratio history for Sarepta Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.10-15.9%
20237.26-40.49%
202212.29.13%
202111.2-55.15%
202024.9-2.22%
201925.5-1.12%
201825.810.75%
201723.3-91.58%
2016276-80.34%
2015> 10002193.16%
201461.313.28%
201354.1146.82%
201221.9918.16%
20112.15-73.42%
20108.10-11.73%
20099.17316.41%
20082.20-73.37%
20078.27-99.44%
2006> 10003874.02%
200536.9-81.29%
200419736.42%
2003145-8.87%
2002159-55.81%
2001359

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.82 50.76%๐Ÿ‡บ๐Ÿ‡ธ USA
1.45-54.84%๐Ÿ‡บ๐Ÿ‡ธ USA
333 10,310.28%๐Ÿ‡บ๐Ÿ‡ธ USA
3.42 6.99%๐Ÿ‡บ๐Ÿ‡ธ USA
15.3 376.79%๐Ÿ‡บ๐Ÿ‡ธ USA
4.73 47.85%๐Ÿ‡บ๐Ÿ‡ธ USA
36.0 1,025.88%๐Ÿ‡บ๐Ÿ‡ธ USA